Unichem Lab shares rise over 12% after USFDA approval for hypertension drugShares of the drug firm gained 7.04 per cent to trade at Rs 164 on the BSE.
25 Nov, 2019, 03.40 PM IST
Natco Pharma's marketing partner gets USFDA approval for chest pain tabletsNitroglycerin Sublingual Tablets had total annual sales of around USD 77.3 million.
08 May, 2019, 11.43 AM IST
Lupin launches generic antidepressant tablets in USThe company has launched its Fluoxetine tablets USP in the strength of 60mg after having received an approval from the United States Food a...
10 Apr, 2019, 02.28 PM IST
Buy Dr. Reddy's Laboratories, target Rs 3,350: Edelweiss Financial ServicesBuy Dr. Reddy's Laboratories Ltd. at a price target of Rs 3350.0 .
22 Nov, 2018, 03.37 PM IST
‘Nod to sell Opioid drug in US positive for Dr Reddy’s stock’The company can resume at-risk launch of Suboxone with favourable ruling from the appeals court.
22 Nov, 2018, 08.58 AM IST
Natco's partner Alvogen gets nod for influenza drug in USIn December last year, Alvogen launched the first generic equivalent to oseltamivir phosphate capsules in the United States.
03 Nov, 2017, 01.54 PM IST
Natco Pharma launches Tamiflu generic capsules in USThe company's capsules are generic versions of Roche's Tamiflu drug
12 Dec, 2016, 11.53 AM IST
Natco Pharma gets USFDA nod for generic Budesonide capsulesThe company has received "final approval of abbreviated new drug application from the US Food and Drug Administration for generic version o...
24 Nov, 2016, 03.13 PM IST
Natco Pharma surges 7% on drug approvalThe stock rose 7.33 per cent to hit a high of Rs 650.90 on BSE. Volumes more than doubled on the counter to 98,000 shares, compared with a ...
04 Aug, 2016, 11.40 AM IST
Natco Pharma gets ANDA nod for Tamiflu's generic versionTamiflu is used to treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than 2 days.
04 Aug, 2016, 10.46 AM IST
Natco settles patent suit with Gilead, others over TamifluNatco Pharma and its partner Alvogen today said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu.
14 Dec, 2015, 11.37 AM IST
- Strides Arcolab gets USFDA nod for its generic anti-bacterial capsules
Strides Arcolab plans to immediately launch the product through US-headquartered firm Alvogen on a profit sharing basis.
11 Apr, 2012, 01.02 PM IST